Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.

The female protective effect against autism spectrum disorder

Open access

Preprint — published as 10.1016/j.xgen.2022.100134 · Paper page

Abstract

Autism spectrum disorder (ASD) is diagnosed 3-4 times more frequently in males than in females. Genetic studies of rare variants support a female protective effect (FPE) against ASD. However, sex differences in common, inherited genetic risk for ASD are less studied. Leveraging the nationally representative Danish iPSYCH resource, we found siblings of female ASD cases had higher rates of ASD than siblings of male ASD cases ( P < 0.01). In the Simons Simplex and SPARK collections, mothers of ASD cases carried more polygenic risk for ASD than fathers of ASD cases ( P = 7.0 × 10 −7 ). Male unaffected siblings under-inherited polygenic risk ( P = 0.03); female unaffected siblings did not. Further, female ASD cases without a high-impact de novo variant over-inherited nearly three-fold the polygenic risk of male cases with a high-impact de novo ( P = 0.02). Our findings support a FPE against ASD that includes common, inherited genetic variation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.03.29.21253866

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Figures

Graphical abstract
Graphical abstract CC BY · PubMed Central
Figure 1 Sibling recurrence of ASD and ID Red bars represent odds ratios (ORs) for siblings of female cases, and teal bars represent ORs for siblings of male cases. ORs indicate the increase in risk for each diagnosis among siblings of cases, as compared with age- and sex-matched controls, derived from logistic regression (STAR Methods; Sibling recurrence of ASD and ID). Error bars represent 95% confidence intervals. p values are from a Wald test to determine whether ORs are significantly different from one another. p values for the male-female comparison were only calculated when both ORs were significantly different from 1. Underlying data are in Tables S1 and S2.
Figure 1 Sibling recurrence of ASD and ID Red bars represent odds ratios (ORs) for siblings of female cases, and teal bars represent ORs for siblings of male cases. ORs indicate the increase in risk for each diagnosis among siblings of cases, as compared with age- and sex-matched controls, derived from logistic regression (STAR Methods; Sibling recurrence of ASD and ID). Error bars represent 95% confidence intervals. p values are from a Wald test to determine whether ORs are significantly different from one another. p values for the male-female comparison were only calculated when both ORs were significantly different from 1. Underlying data are in Tables S1 and S2.CC BY · PubMed Central
Figure 2 The continuum of ASD polygenic risk in the general population and families with an ASD case Between-group differences in polygenic score for ASD and p values from linear regression comparing group polygenic scores while controlling for 15 principal components of ancestry. ASD groups are combined across the SSC and SPARK collections. Autosomal polygenic risk scores were calculated using weights from a GWAS of ASD cases (n = 19,870) and controls (n = 39,078) from the iPSYCH consortium in Denmark (STAR Methods: Generation of polygenic risk score). Group differences are standardized using the UK Biobank ASD PRS distribution. Underlying data are in Tables S3–S6.
Figure 2 The continuum of ASD polygenic risk in the general population and families with an ASD case Between-group differences in polygenic score for ASD and p values from linear regression comparing group polygenic scores while controlling for 15 principal components of ancestry. ASD groups are combined across the SSC and SPARK collections. Autosomal polygenic risk scores were calculated using weights from a GWAS of ASD cases (n = 19,870) and controls (n = 39,078) from the iPSYCH consortium in Denmark (STAR Methods: Generation of polygenic risk score). Group differences are standardized using the UK Biobank ASD PRS distribution. Underlying data are in Tables S3–S6.CC BY · PubMed Central
Figure 3 Polygenic transmission disequilibrium in ASD cases and unaffected siblings Transmission disequilibrium standardized to the mid-parent PRS distribution with error bars denoting 95% confidence intervals. p values are from a two-sided, one-sample t test and estimate the probability that polygenic deviation is equal to 0. Cases and controls are combined across SSC and SPARK cohorts. The mother and father PRS mean lines are the mean values from pTDT of each parent against the mid-parent expectation (symmetric by definition). Summary statistics for the PRS are from a GWAS of ASD cases (n = 19,870) and controls (n = 39,078) from the iPSYCH consortium in Denmark (STAR Methods: Danish ASD GWAS). Underlying data are in Table S7.
Figure 3 Polygenic transmission disequilibrium in ASD cases and unaffected siblings Transmission disequilibrium standardized to the mid-parent PRS distribution with error bars denoting 95% confidence intervals. p values are from a two-sided, one-sample t test and estimate the probability that polygenic deviation is equal to 0. Cases and controls are combined across SSC and SPARK cohorts. The mother and father PRS mean lines are the mean values from pTDT of each parent against the mid-parent expectation (symmetric by definition). Summary statistics for the PRS are from a GWAS of ASD cases (n = 19,870) and controls (n = 39,078) from the iPSYCH consortium in Denmark (STAR Methods: Danish ASD GWAS). Underlying data are in Table S7.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 137

Metadata

Authors
Wigdor, E. M., Weiner, D. J., Grove, J., Fu, J. M., Thompson, W. K., Carey, C. E., Baya, N., van der Merwe, C., Walters, R. K., Satterstrom, F. K., Palmer, D. S., Rosengren, A., Bybjerg-Grauholm, J., iPSYCH Consortium, Hougaard, D. M., Mortensen, P. B., Daly, M. J., Talkowski, M. E., Sanders, S. J., Bishop, S. L., Børglum, A. D., & Robinson, E. B.
Affiliations
  • Broad Institute (US)
  • Aarhus University (DK)
  • Laureate Institute for Brain Research (US)
  • Sankt Hans Hospital (DK)
  • Statens Serum Institut (DK)
  • University of California, San Francisco (US)
Corresponding author
Robinson, Elise B.
Venue
Cell Genomics
Publisher
openRxiv
Published
2021-04-04
Volume
2
Issue
6
Pages
100134-100134
ISSN
2666-979X (ISSN-L)
OpenAlex
W4286450915
Cited by
124
References
70
Citations by year
2026: 29 · 2025: 25 · 2024: 30 · 2023: 26 · 2022: 12 · 2021: 1
FWCI
13.54
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Cell Genomics (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • Massachusetts General Hospital
  • Harvard University
  • Aarhus Universitet (31063)
  • Partners Healthcare (2015P002376)
  • Autism Science Foundation
  • Broad Institute
  • Lundbeckfonden (R155-2014-1724, R102‐A9118, R248‐2017‐2003, R102-A9118, R155-2014-1724, and R248-2017-2003, R102-A9118, R155-2014-1724, and R248-2017-2003)
  • Novo Nordisk
  • Novo Nordisk Fonden
  • H. Lundbeck A/S
  • Horizon 2020 Framework Programme (667302, EU‐H2020)
  • HORIZON EUROPE Framework Programme (667302)
  • Department of Medicine, Georgetown University
  • National Institute of Mental Health (U01MH109514, F30MH129009, U01MH111662, R01MH111813, RMH111813A)
  • National Institute of General Medical Sciences (T32GM007753)
  • U.S. National Library of Medicine (T15LM007092)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
autism spectrum disorder, sex differences, polygenic risk score, familial aggregation, siblings, maternal inheritance, Simons Simplex Collection, SPARK cohort

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The female protective effect against autism spectrum disorder. https://app.cochat.ai/papers/10.1101/2021.03.29.21253866
The paper
Wigdor, E. M., Weiner, D. J., Grove, J., Fu, J. M., Thompson, W. K., Carey, C. E., Baya, N., van der Merwe, C., Walters, R. K., Satterstrom, F. K., Palmer, D. S., Rosengren, A., Bybjerg-Grauholm, J., iPSYCH Consortium, Hougaard, D. M., Mortensen, P. B., Daly, M. J., Talkowski, M. E., Sanders, S. J., . . . Robinson, E. B. (2021). The female protective effect against autism spectrum disorder. Cell Genomics. https://doi.org/10.1101/2021.03.29.21253866

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.